4
Changes in Ownership
PROTHENA CORP PUBLIC LTD CO Filed Acc 0001567619-22-013840
Chief Medical Officer sold 8,000 shares at $30.00 ($240,000)
- Chief Medical Officer acquired 8,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Garren Hideki Chief Medical Officer | 2022-07-06 | Option exercise | +8,000 | $24.90 | $199,200 | 8,000 | D: show line 1 in the form |
| Garren Hideki Chief Medical Officer | 2022-07-06 | Sale | −8,000 | $30.00 | $240,000 | 0 | D: show line 2 in the form |
| Open-market sales · 8,000 sh · avg $30.00 · $240,000 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Garren Hideki Chief Medical Officer | 2022-07-06 | Option exercise · Stock Option (Right to Buy) | −8,000 | 242,000 | D: show line 3 in the form |
Loading xslF345X03/doc1.xml…